These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24696531)

  • 1. Severity of hepatitis C virus (genotype-3) infection positively correlates with circulating microRNA-122 in patients sera.
    Kumar S; Chawla YK; Ghosh S; Chakraborti A
    Dis Markers; 2014; 2014():435476. PubMed ID: 24696531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNAs as potential biomarkers of physical activity in geriatric patients with HCV.
    Al-Rawaf HA; Gabr SA; Iqbal A; Alghadir AH
    BMC Mol Cell Biol; 2024 Jul; 25(1):18. PubMed ID: 39030480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNAs as predictive biomarkers for liver disease progression of chronic hepatitis C (genotype-4) Egyptian patients.
    El-Hefny M; Fouad S; Hussein T; Abdel-Hameed R; Effat H; Mohamed H; Abdel Wahab AH
    J Med Virol; 2019 Jan; 91(1):93-101. PubMed ID: 30133717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating microRNA-196a as a candidate diagnostic biomarker for chronic hepatitis C.
    Liu B; Xiang Y; Zhang HS
    Mol Med Rep; 2015 Jul; 12(1):105-10. PubMed ID: 25738504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3.
    Oliveira KG; Malta FM; Nastri AC; Widman A; Faria PL; Santana RA; Alves VA; Carrilho FJ; Pinho JR
    Med Microbiol Immunol; 2016 Apr; 205(2):111-7. PubMed ID: 26272127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression.
    Shrivastava S; Petrone J; Steele R; Lauer GM; Di Bisceglie AM; Ray RB
    Hepatology; 2013 Sep; 58(3):863-71. PubMed ID: 23390075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
    Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
    Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs as a biomarker to predict therapy efficacy in hepatitis C patients with different genotypes.
    Fan Z; Zhang Q; Chen H; He P; Li Y; Si M; Jiao X
    Microb Pathog; 2017 Nov; 112():320-326. PubMed ID: 28993299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.
    Lee TH; Matta B; King BD; Hodges MR; Tillmann HL; Patel K
    J Med Virol; 2015 Oct; 87(10):1722-6. PubMed ID: 25963774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs (miR-21, miR-223, miR-885-5p) along the clinical spectrum of HCV-related chronic liver disease in Egyptian patients.
    Nasser MZ; Zayed NA; Mohamed AM; Attia D; Esmat G; Khairy A
    Arab J Gastroenterol; 2019 Dec; 20(4):198-204. PubMed ID: 31806407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs as predictor markers for response to interferon treatment of chronic hepatitis C genotype-4 in Egyptian patients.
    Motawi TM; Rizk SM; Shaker OG; Mokhtar OZ
    PLoS One; 2015; 10(3):e0121524. PubMed ID: 25811198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of circulating miRNA-122 for hepatitis B virus and/or hepatitis C virus-associated chronic viral hepatitis.
    Zhou X; Fang S; Wang M; Xiong A; Zheng C; Wang J; Yin C
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31427483
    [No Abstract]   [Full Text] [Related]  

  • 13. Micro-RNA-122 levels in acute liver failure and chronic hepatitis C.
    Dubin PH; Yuan H; Devine RK; Hynan LS; Jain MK; Lee WM;
    J Med Virol; 2014 Sep; 86(9):1507-14. PubMed ID: 24895202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Serum Alpha-Fetoprotein Level in Chronic Hepatitis C Patients.
    Yang N; Li Z; Yan M; Xiao W; Zhang W; Long Y; Cheng Y; Ming K; Xu B
    Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of miR-122 level in the plasma of chronically HCV infected patients].
    Gholami M; Ravanshad M; Alavian SM; Baesi K; Moallemi S
    Mol Biol (Mosk); 2016; 50(2):279-83. PubMed ID: 27239848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer.
    Motawi TM; Sadik NA; Shaker OG; Ghaleb MH
    Tumour Biol; 2016 Jul; 37(7):9865-74. PubMed ID: 26812693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease.
    Cermelli S; Ruggieri A; Marrero JA; Ioannou GN; Beretta L
    PLoS One; 2011; 6(8):e23937. PubMed ID: 21886843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.
    Bihrer V; Friedrich-Rust M; Kronenberger B; Forestier N; Haupenthal J; Shi Y; Peveling-Oberhag J; Radeke HH; Sarrazin C; Herrmann E; Zeuzem S; Waidmann O; Piiper A
    Am J Gastroenterol; 2011 Sep; 106(9):1663-9. PubMed ID: 21606975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in circulating MMP-9 levels with regard to viral load and AST:ALT ratio between chronic hepatitis B and C patients.
    Helaly GF
    Br J Biomed Sci; 2011; 68(1):38-42. PubMed ID: 21473261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of chronic hepatitis C infection on cholesterol metabolism in PBMCs is associated with microRNA-146a expression.
    Sidorkiewicz M; Grek M; Jozwiak B; Krol A; Piekarska A
    Eur J Clin Microbiol Infect Dis; 2017 Apr; 36(4):697-702. PubMed ID: 27888401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.